Patients need ongoing guidance, clear progress tracking, structured coaching touchpoints, and easy access to their care plan
Can you implement lifestyle modifications
The Monitoring Program includes substances which are not on the Prohibited List, but that WADA wishes to monitor in order to detect potential patterns of misuse in sport. A spokesperson for Novo Nordisk said in a statement that the pharmaceutical company, which produces and distributes GLP-1s, agreed with WADAs decision to monitor GLP-1 usage: We are supportive of the WADA recommendation, and we strongly discourage use/promotion outside the indicated population and approved label. Advertisement A spokesperson for Eli Lilly, another company that manufactures and distributes GLP-1s, said: Zepbound (tirzepatide) and Foundayo (orforglipron) are indicated for use, along with diet and exercise, for adults with obesity or overweight and a weight-related comorbidity
If Willow ceases operations, you would need to find a new provider immediately to avoid treatment interruption
Eli Lilly is also assessing the safety and efficacy of retatrutide for chronic weight management and in patients with knee osteoarthritis and obstructive sleep apnea, as part of its TRIUMPH Phase III development program
For reproducibility, labs should confirm composition and analytical details using the lot-specific Certificate of Analysis (CoA) and internal QC records